Possible supportive effects of co-dergocrine mesylate on antioxidant enzyme systems in aged rat brain

European Neuropsychopharmacology

Volumn 8, Issue 1, 1998, Pages 13-16

  Sözmen, Eser Yildirim ^a   Kanit, Lütfiye ^a   Kutay, Fatma Z ^a   Hariri, Nuran I ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Aging; CAT; MAO; Rat brain; SOD

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIOXIDANT; CATALASE; DIHYDROERGOTOXINE MESILATE; FREE RADICAL; SUPEROXIDE DISMUTASE;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; CATALASE; ERGOLOID MESYLATES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 0344973027     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00039-4     Document Type: Article

References (17)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105:1984;121-126.
2. Bourre, J.M., 1992. Protection against by radicals in cerebral capillaries. In: Packer L., Prilipko, L., Christen, Y. (Eds.), Free Radicals in the Brain. Aging, Neurological and Mental Disorders. Springer Verlag, Berlin, pp. 41-48.
3. Büyüköztürk A., Kamt L., Ersöz B., Menteş G., Hariri N.I The effects of hydergine on the MAO activity of the aged and adult rat brain. Eur. Neuropsychopharmacol. 5:1995;527-529.
4. Carillo M.-C., Kanai S., Sato R., Kitano K. Age-related changes in antioxidant enzyme activities are region and organ, as well as sex selective in the rat. Mech. Ageing Dev. 65:1992;187-198.
5. Etsuo N. Interation of ascorbate and alpha-tocopheral. Ann. NY Acad. Sci. 498:1987;186-199.
6. Halliwell, B., Gutteridge, J.M.C., 1985. Free Radicals in Biology and Medicine, Clarendon Press, Oxford.
7. Halliwell, B., Paker, L., 1992. Reactive Oxygen Species and the Central Nervous System in Mental Disorders. Springer Verlag, Berlin, pp. 21-40.
8. Harman, D., 1992. Role of free radicals in aging and disease, In: Fabris, N., Harman, D., Knook, D.L., Steinhagen-Thiessen, E. (Eds.), Physiopathological Processes of Aging. Annals of the New York Academy of Sciences, Vol. 673.
9. 3H] deprenyl. Brain Res. 547:1991;69-76.
10. Knoll J. Rationale for (-) deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. Biomed-Pharmacother. 49(4):1995;187-195.
11. Luck, H., 1983. Catalase. In: Bergmeyer, H.U. (Eds) Methods of Enzymatic Analysis Vol. III, Verlag Chemie, Weinheim, p. 279.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. 193:1951;265-275.
13. Misra H.P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247:1972;3170-3175.
14. Packer, L., 1992. Free radical scavengers and antioxidants in prophylaxy and treatment of brain diseases. In: Packer, L., Prilipko, L., Christen, Y. (Eds.), Free Radicals in the Brain. Aging, Neurological and Mental Disorders, pp. 1-20.
15. Strolin Benedetti M., Dostert P. Monoamine oxidase, brain aging and degenerative diseases. Biochem. Pharmacol. 38:1989;555-561.
16. Voitenko N.N., Chrisp P. Brain monoamine oxidase during aging. Vopr. Med. Khim. 37:1992;28-31.
17. Wadworth, A.N. and Chrisp, P., 1992. Co-dergocrine mesylate. A review of its pharmacokinetic properties and therapeutic use in age related cognitive decline. Drugs-Aging 2, 153-173.